Assessing Deep-Tech Innovation Hubs in Germany

Recognizing the European Union‘s shortcomings in translating scientific research into commercially viable deep-tech solutions, this report introduces a comprehensive index designed to evaluate the regional strengths and challenges within Germany‘s biotech landscape. The study examines five key German biotech hubs, focusing on key stages in the biotech innovation process – from fundamental research to venture capital funding and commercialization – while also considering enabling factors such as public infrastructure and business environment. This quantitative analysis is further enriched by in-depth interviews with seasoned venture capitalists who specialize in biotech entrepreneurship and investment.